Radioprotection with cytokines--learning from nature to cope with radiation damage
- PMID: 1777360
Radioprotection with cytokines--learning from nature to cope with radiation damage
Abstract
The quest for methods to protect cells from the damaging effects of ionizing radiation led to the observation that cytokines, endogenously produced hormone-like polypeptides, are radioprotective. Interleukin-1 and tumor necrosis factor-alpha, given before irradiation, can protect mice from doses of radiation that would be fatal to untreated animals. At lower doses of radiation, the hemopoietic growth factors, interleukin-1, interleukin-4, interleukin-6, tumor necrosis factor-alpha, interferon, and leukemia inhibitory factor can promote recovery when administered after irradiation. Exposure to ionizing radiation selectively induces expression of some cytokines. Recent work suggests that certain cytokines may initiate autocrine/paracrine regulated recovery and repair pathways. Thus, the radioprotective and therapeutic effects of supplementary pharmacological doses of cytokines may act by amplifying innate defenses to ionizing radiation.
Comment in
-
Radioprotection with cytokines: a clarification of terminology.Cancer Cells. 1991 Nov;3(11):457. Cancer Cells. 1991. PMID: 1760247 No abstract available.
Similar articles
-
Modulation of radiation damage by cytokines.Stem Cells. 1997;15 Suppl 2:87-94. doi: 10.1002/stem.5530150713. Stem Cells. 1997. PMID: 9368290 Review.
-
Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.J Immunol. 1988 Jan 1;140(1):108-11. J Immunol. 1988. PMID: 2447166
-
Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis.Biol Blood Marrow Transplant. 1999;5(4):204-14. doi: 10.1053/bbmt.1999.v5.pm10465100. Biol Blood Marrow Transplant. 1999. PMID: 10465100
-
Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow.Bone Marrow Transplant. 1993 Dec;12(6):551-63. Bone Marrow Transplant. 1993. PMID: 8136738 Review.
-
Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.Cancer Res. 1991 May 1;51(9):2379-85. Cancer Res. 1991. PMID: 2015601
Cited by
-
Modifying radiation damage.Curr Drug Targets. 2010 Nov;11(11):1352-65. doi: 10.2174/1389450111009011352. Curr Drug Targets. 2010. PMID: 20583981 Free PMC article. Review.
-
Development of a combined radiation and burn injury model.J Burn Care Res. 2011 Mar-Apr;32(2):317-23. doi: 10.1097/BCR.0b013e31820aafa9. J Burn Care Res. 2011. PMID: 21233728 Free PMC article.
-
Radioprotective effects of the immunostimulating lauroylpeptide LtriP (RP 56142).Experientia. 1993 Feb 15;49(2):160-6. doi: 10.1007/BF01989422. Experientia. 1993. PMID: 8440352
-
Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents.J Exp Med. 1992 Oct 1;176(4):1043-51. doi: 10.1084/jem.176.4.1043. J Exp Med. 1992. PMID: 1402650 Free PMC article.
-
Synergistic protecting effect of cord blood CD34+ cells over-expressing both interleukin-3 and Flt3 ligand on lethally irradiated mice.Int J Hematol. 2009 Jul;90(1):64-73. doi: 10.1007/s12185-009-0348-8. Epub 2009 Jun 16. Int J Hematol. 2009. PMID: 19529981
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources